Thompson Reuters Business Models Event
IPBC Asia

Blog

03 Jul 2015

Appraiser puts $113 million price tag on steel company's intangibles; but will investors buy Chinese IP valuations?

Last week Sutor Technology Group announced that an independent valuation of the intellectual property owned by it and its subsidiaries had arrived at a figure of Rmb700 million (approximately US$113 million). The Chinese steel manufacturer and service provider is publicly traded on the NASDAQ exchange, and while a relatively small Chinese company putting a price on its intangible assets is no longer a novel proposition, it does raise the question of how much stock outside investors will be Read more

Jacob Schindler

02 Jul 2015

Despite patent slowdown, investor appetite for intangibles has never been higher, says man who sold RadioShack assets

Last week the disposal of a range of intangible assets owned by RadioShack was completed, raising around $40 million for the bankrupt business. The sale included a range of trademarks, domain names and a small portfolio of 73 granted and pending patents. The assets were largely focused on the US, but also included trademarks in Mexico, Latin America, the Middle East and North Africa. Masterminding the sale process – which was done through an auction – was a team of advisers Read more

Richard Lloyd

02 Jul 2015

Patent enforcement pioneer’s multi-million dollar victory indicates that China damages are on the up

Computing storage solutions developer Netac Technology has been awarded Rmb40 million (approximately US$6.45 million) in damages after a court in China’s Guangxi autonomous region found that products made by Beijing IT manufacturer Watertek had infringed one of its patents relating to flash drive technology. Shenzhen-based Netac filed suit in the Nanning Intermediate People’s Court in May 2012, alleging that Watertek’s ComyiKEY220 USB drive infringed its Chinese invention Read more

Jack Ellis

01 Jul 2015

Announcing a major new event focused on how legal and legislative changes are affecting the US patent market

On 17th November, IAM hosts a unique event at the Ronald Reagan Building and International Trade Centre in Washington DC. Patent Law and Policy: Courts, Congress and the Monetisation Landscape is a one day conference focusing on the ways in which those looking to do patent-based transactions in the US have been affected by ongoing legislative action and court decisions, what is in store over the coming years and how to build successful strategies in today's challenging landscape. It Read more

Joff Wild

30 Jun 2015

We may now be reaching the point when PIPCO deals begin to take place

Half-way through 2015, it’s clear that this has not been an easy six-months for most in the public IP company (PIPCO) market. Even Marathon, once the darling of the sector, has been hit, with its share price currently just under $3 (compared with a 52-week high of $9.73). Acacia, one of the largest players, has seen its stock drop below $9, close to its low for the year. The prevailing conditions, particularly for those PIPCOs formed in a flurry of reverse mergers a few years ago, Read more

Richard Lloyd

29 Jun 2015

NPE assertion campaign using LG patents may mark the dawn of a new reality for Korean corporates

An entity named Evolved Wireless last week launched lawsuits against a number of major companies claiming that they are infringing several of its patents which were previously owned by LG Electronics. The assertion campaign could well signal a new, more aggressive approach from the South Korean company as it attempts to increase returns from its extensive patent portfolio - and may be quid pro quo after it 'opened' a large number of its patents, along with other companies in LG Read more

Jack Ellis

28 Jun 2015

Two big developments last week mean that Europe's unitary patent system may be up and running next year

There were two big pieces of news concerning the European unitary patent and the unified patent court (UPC) last week – one potential, the other actual. On Wednesday the IP Kat blog had a major scoop when it revealed that the UK IP Office had released the following brief statement about the UK’s ratification of the UPC Agreement: The Government is committed to this project and wants the UK to be part of a European patent system that supports growth and fosters innovation. The Read more

Joff Wild

26 Jun 2015

Despite recent patent disposal Inventergy at risk of being kicked off the Nasdaq

Inventergy’s share price immediately jumped Thursday on the news that it had executed an agreement for the sale of two patent families with an unnamed company for $4 million. However, on Friday morning it lost some of its previous day’s gain and at around 36 cents per share, the NPE’s stock remained well short of the $1 level that it needs to maintain by the end of this month to be assured of remaining on the Nasdaq. According to Inventergy’s last annual report its Read more

Richard Lloyd

26 Jun 2015

BlackBerry's deal with Cisco could mark the Canadian company's coming of age as a big patent licensor

No-one willingly pays to license patents is an old adage and a very accurate one. There are few to which it applies with more vigour than Cisco. So, the news a few days back that the company had entered into a cross-licensing agreement with BlackBerry, under which the Canadian business will also receive a licensing fee from its American partner, should be seen as pretty significant. In June 2014, Blackberry hired Mark Kokes from InterTrust to be its VP of IP & Standards; a couple of Read more

Joff Wild

26 Jun 2015

SIPO rejects Sovaldi patent as Chinese regulators turn attention to drug prices

China's State Intellectual Property Office (SIPO) last week rejected a patent application related to the hepatitis C drug Sovaldi, which is produced by Gilead Sciences. The US company already owns a Chinese patent on the drug’s main ingredient sofosbuvir, the patent rejected here was for a ‘prodrug’, which activates the compound once it is in the patient’s body. Sovaldi enjoys a 90% success rate in treating hepatitis C patients, of which there are 29 million in Read more

Jacob Schindler

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 0